Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential proton pump inhibitor–related adverse effects
Issac E. Perry, Irene Sonu, Carmelo Scarpignato, et al.
Annals of the New York Academy of Sciences (2020) Vol. 1481, Iss. 1, pp. 43-58
Closed Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Treatment of gastric ulcer, traditional Chinese medicine may be a better choice
Haiying Gong, Ning Zhao, Conglei Zhu, et al.
Journal of Ethnopharmacology (2024) Vol. 324, pp. 117793-117793
Closed Access | Times Cited: 20
Proton pump inhibitors may enhance the risk of digestive diseases by regulating intestinal microbiota
Tian Liang, Chongfei Huang, Wenkang Fu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20
Network pharmacology analysis reveals potential targets and mechanisms of proton pump inhibitors in breast cancer with diabetes
Haihong Hu, Hanbin Wang, Xiaoyan Yang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Proton pump inhibitors associated acute kidney injury and chronic kidney disease: data mining of US FDA adverse event reporting system
Bin Wu, Dan Li, Ting Xu, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 37
Keverprazan, a novel potassium‐competitive acid blocker: Multiple oral doses safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy subjects
Sufeng Zhou, Lijun Xie, Chen Zhou, et al.
Clinical and Translational Science (2023) Vol. 16, Iss. 10, pp. 1911-1922
Open Access | Times Cited: 13
A pharmacovigilance study of association between proton pump inhibitor and dementia event based on FDA adverse event reporting system data
Bin Wu, Qiaozhi Hu, Fangyuan Tian, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 32
Helicobacter pylori eradication with high-dose proton pump inhibitor-amoxicillin dual therapy: A systematic review and meta-analysis
Jia-Ai Yeh, Huei‐Kai Huang, Ai-Li Chou, et al.
International Journal of Antimicrobial Agents (2024) Vol. 63, Iss. 6, pp. 107159-107159
Closed Access | Times Cited: 4
Effects of proton pump inhibitors on inflammatory bowel disease: An updated review
Liang Yu, Zhen Meng, Xueli Ding, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 21, pp. 2751-2762
Open Access | Times Cited: 4
Highly effective photostabilization of polyvinyl chloride films using omeprazole-tin additive complexes
Sarah Basil Fawzi Fawzi, Emad͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏͏ Yousif, Khalid Zainulabdeen, et al.
Journal of Umm Al-Qura University for Applied Sciences (2025)
Open Access
Potentially Inappropriate Medication and Polypharmacy in Nursing Home Residents: A Cross-Sectional Study
Raquel Díez, Raquel Cadenas, Julen Susperregui, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 13, pp. 3808-3808
Open Access | Times Cited: 17
Keverprazan, a novel potassium-competitive acid blocker: Single ascending dose safety, tolerability, pharmacokinetics, pharmacodynamics and food effect in healthy subjects
Sufeng Zhou, Lijun Xie, Chen Zhou, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 190, pp. 106578-106578
Open Access | Times Cited: 9
Proton pump inhibitors, bone and phosphocalcic metabolism
Cécile Philippoteaux, Julien Paccou, Emmanuel Chazard, et al.
Joint Bone Spine (2024) Vol. 91, Iss. 5, pp. 105714-105714
Closed Access | Times Cited: 3
Bi-Directionality of the Microbiota-Gut-Brain Axis in Patients With Functional Dyspepsia: Relevance of Psychotherapy and Probiotics
Sophia Kristina Rupp, Andreas Stengel
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 13
Gut microbiota and functional dyspepsia: a two-sample Mendelian randomization study
Yichuan Xv, Jiaxu Chen, Lin Jiang
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 2
A pragmatic assessment of proton pump inhibitors vs. histamine type 2 receptor antagonists on clinically important gastrointestinal bleeding and mortality when used for stress ulcer prophylaxis in the ICU
Carly Boyd, Tanna Hassig, Robert MacLaren
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2021) Vol. 41, Iss. 10, pp. 820-827
Closed Access | Times Cited: 14
Protocol of a randomized, double-blind, placebo-controlled study of the effect of probiotics on the gut microbiome of patients with gastro-oesophageal reflux disease treated with rabeprazole
Wenjun Liu, Yong Xie, Yingmeng Li, et al.
BMC Gastroenterology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Stimulus-responsive biomaterials for Helicobacter pylori eradication
Tiantian Shan, Xi Chen, Xinxuan Zhou, et al.
Journal of Advanced Research (2023) Vol. 66, pp. 209-222
Open Access | Times Cited: 4
Proton-pump inhibitor-induced bone loss is preventable by concomitant use of a long-acting somatostatin analogue.
Farhad Koohpeyma, Samaneh Taghiyan, Mesbah Shams
PubMed (2024) Vol. 27, Iss. 2, pp. 165-169
Closed Access | Times Cited: 1
Efficacy evaluation and exploratory analysis of influencing factors of Banxia Houpu Decoction in the treatment of refractory gastroesophageal reflux disease
Shunzhe Song, Yunshu Zhang, J W Zhang, et al.
Medicine (2024) Vol. 103, Iss. 24, pp. e38045-e38045
Open Access | Times Cited: 1
Focal Adhesion Kinase and Colony Stimulating Factors: Intestinal Homeostasis and Innate Immunity Crosstalk
Nicholas D. Brown, Emilie E. Vomhof‐DeKrey
Cells (2024) Vol. 13, Iss. 14, pp. 1178-1178
Open Access | Times Cited: 1
Proton Pump Inhibitors and Oral–Gut Microbiota: From Mechanism to Clinical Significance
Xian Zhang, Qing Li, Siyuan Xia, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2271-2271
Open Access | Times Cited: 1
Knowledge, Attitude, and Practices Regarding Proton Pump Inhibitors among Community Pharmacists and Pharmacy Students
E Hamurtekin, Ahmet Sami Boşnak, Abnoos Azarbad, et al.
Nigerian Journal of Clinical Practice (2023) Vol. 26, Iss. 2, pp. 201-210
Open Access | Times Cited: 3
Whether long-term use of proton pump inhibitor increases the risk of precancerous lesions in the stomach: A systematic review and meta-analysis of randomized controlled trials
F Lv, Jincheng Wang, Leiming Mao, et al.
Medicine (2023) Vol. 102, Iss. 38, pp. e35062-e35062
Open Access | Times Cited: 3
Effect of potassium-competitive acid blockers on human gut microbiota: a systematic review and meta-analysis
Meng-Ling Ouyang, Shu-Peng Zou, Qian Cheng, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Acid-Suppressive Drugs and Risk of Fracture in Children and Young Adults: A Meta-Analysis of Observational Studies
Jiangbi Li, Xiaoping Xie, Weibin Liu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top